Voluntary Licensing Agreement for New-Generation Cancer Medicine Broadens Patient Access in Morocco and Egypt
In what is a significant milestone in broadening the availability of cancer treatments in Morocco and Egypt, biopharmaceutical manufacturer Novartis recently established a voluntary licensing agreement with the Medicines Patent Pool (MPP) to increase patient access to a medicine used to treat chronic myeloid leukemia (CML).
A new report, Global Innovation Index 2022, from the World Intellectual Property Organization (WIPO) indicates that research and development (R&D) investments thrived at the height of the COVID-19 pandemic in 2020 and continued to boom in 2021. This spike in innovation occurred despite the global recession and economic lockdowns in many countries, pointing to the importance of innovation for pandemic solutions and recovery.
As the world prepares for future public health threats to emerge, it’s imperative public and private sector leaders are collaborating to address these challenges with innovative treatments and solutions.
This week, the 75th World Health Assembly (WHA) will convene key leaders from 194 member states in Geneva to discuss some of the most pressing challenges impacting global public health, with this year’s theme focusing on “health for peace and peace for health.” As the COVID-19 pandemic continues to weigh on global public health systems,